Answers are grounded in this paper and cite their sources.
This opinion piece describes major limitations of using α-synuclein in speculative neuronally enriched for diagnosing or predicting Parkinson's disease risk from prodromal conditions such as REM behaviour disorder. It concludes that such an approach is unreliable and recommends that future researchers divert away to more widely accepted approaches such as seed amplification assays.
No takes yet. Share an insight, caveat, or question.
Hash Brown Taha (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: